Document Type : Hypothesis


University of the Americas



The approval of the mRNA vaccine technique against COVID-19 opens a door to research and the creation of new drugs against different infectious pathologies or even cancer, since for several diseases the therapeutic options are limited, and different viral diseases They are treated only symptomatically. For these reasons, this study proposes a hypothesis supported by biological studies, which have been indexed in SciELO, Medline, PubMed and Scopus, in such a way that it provides a theoretical basis for the possible development of a drug that uses the mRNA technique and the ribonucleolytic action of a ribonuclease for a possible antiviral therapy, and analyzes a future perspective of this technique, in order to provide a bibliographic basis on this hypothesis and motivate researchers to carry out biological studies on this topic.